Identification of the epidermal growth factor-like domains of thrombomodulin essential for the acceleration of thrombin-mediated inactivation of single-chain urokinase-type plasminogen activator

European Journal of Biochemistry

Volumn 268, Issue 21, 2001, Pages 5562-5569

  Schenk Braat, Ellen A M ^a,c   Morser, John ^b   Rijken, Dingeman C ^a  

^a TNO   (Netherlands)

^b BAYER AG   (Germany)

^c Pharming Group NV   (Netherlands)

Author keywords

Epidermal growth factor like domains; Inactivation; Single chain urokinase type plasminogen activator; Thrombin; Thrombomodulin

Indexed keywords

CHONDROITIN SULFATE; CYANOGEN BROMIDE; EPIDERMAL GROWTH FACTOR; PROTEIN C; PROUROKINASE; THROMBIN; THROMBIN ACTIVATABLE FIBRINOLYSIS INHIBITOR; THROMBOMODULIN;

ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME DEGRADATION; ENZYME INACTIVATION; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN;

ORYCTOLAGUS CUNICULUS; TRIXIS;

EID: 0035722791     PISSN: 00142956     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1432-1033.2001.02487.x     Document Type: Article

References (41)

1. Progress in clinical fibrinolysis
2. The activation of pro-urokinase by plasma kallikrein and its inactivation by thrombin
3. Inactivation of single-chain urokinase (pro-urokinase) by thrombin and thrombin-like enzymes: Relevance of the findings to the interpretation of fibrin-binding experiments
4. Thrombolytic and pharmacokinetic properties of conjugates of urokinase-type plasminogen activator with a monoclonal antibody specific for crosslinked fibrin
5. Fibrin specific thrombolysis by two-chain urokinase-type plasminogen activator cleaved after arginine 156 by thrombin
6. Activation of thromybin-inactivated single-chain urokinase-type plasminogen activator by dipeptidyl peptidase I (cathepsin C)
7. Thrombin stimulation of platelets induces plasminogen activation mediated by endogenous urokinase-type plasminogen activator
8. The kinetics of plasminogen activation by thrombin-cleaved pro-urokinase and promotion of its activity by fibrin fragment E-2 and by tissue plasminogen activator
9. Inactivation of single-chain urokinase-type plasminogen activator (pro-urokinase) by thrombin
10. A sensitive bioimmunoassay for thrombin-cleaved two-chain urokinase-type plasminogen activator in human body fluids
11. The inactivation of single-chain urokinase-type plasminogen activator by thrombin in human subjects
12. Urokinase mediated fibrinolysis in the synovial fluid of rheumatoid arthritis patients may be affected by the inactivation of single chain urokinase type plasminogen activator by thrombin
13. Acceleration of the thrombin inactivation of single-chain urokinase-type plasminogen activator (pro-urokinase) by thrombomodulin
14. Thrombomodulin is a cofactor for thrombin degradation of recombinant single-chain urokinase plasminogen activator 'in vitro' and in a perfused rabbit heart model
15. The inactivation of single-chain urokinase-type plasminogen activator by thrombin in a plasma milieu: Effect of thrombomodulin
16. Inactivation of receptor-bound pro-urokinase-type plasminogen activator (pro-uPA) by thrombin and thrombin/thrombomodulin complex
17. The inactivation of single-chain urokinase-type plasminogen activator by thrombin on cultured human endothelial cells
18. Structure and function of thrombomodulin: A natural anticoagulant
19. Complex formation between thrombin and thrombomodulin inhibits both thrombin-catalyzed fibrin formation and factor V activation
20. The roles of protein C and thrombomodulin in the regulation of blood coagulation
21. TAFI, or plasma procarboxypeptidase B, couples the coagulation and fibrinolytic cascades through the thrombin-thrombomodulin complex
22. On the mechanism of the antifibrinolytic activity of plasma carboxypeptidase B
23. Further localization of binding sites for thrombin and protein C in human thrombomodulin
24. Functional domains of membrane-bound human thrombomodulin. EGF-like domains four to six and the serine/threonine-rich domain are required for cofactor activity
25. Alanine-scanning mutagenesis of the epidermal growth factor-like domains of human thrombomodulin identifies critical residues for its cofactor activity
26. Elements of the primary structure of thrombomodulin required for efficient thrombin-activatable fibrinolysis inhibitor activation
27. Thrombin, thrombomodulin and TAFI in the molecular link between coagulation and fibrinolysis
28. Activation of thrombin-activatable fibrinolysis inhibitor requires epidermal growth factor-like domain 3 of thrombomodulin and is inhibited competitively by protein C
29. Role of the glycosaminoglycan component of thrombomodulin in its acceleration of the inactivation of single-chain urokinase-type plasminogen activator by thrombin
30. Stable expression of a secretable deletion mutant of recombinant human thrombomodulin in mammalian cells
31. Recombinant human thrombomodulin. Regulation of cofactor activity and anticoagulant function by a glycosaminoglycan side chain
32. Modulation of glycosaminoglycan addition in naturally expressed and recombinant human thrombomodulin
33. The short loop between epidermal growth factor-like domains 4 and 5 is critical for human thrombomodulin function
34. A 10-kDa cyanogen bromide fragment from the epidermal growth factor homology domain of rabbit thrombomodulin contains the primary thrombin binding site
35. Cleavage of structural proteins during the assembly of the head of the bacteriophage T4
36. Silver stain for proteins in polyacrylamide gels: A modified procedure with enhanced uniform sensitivity
37. Thrombin interaction with platelet glycoprotein Ib: Effect of glycocalicin on thrombin specificity
38. Equilibrium binding of thrombin to recombinant human thrombomodulin: Effect of hirudin, fibrinogen, factor Va, and peptide analogues
39. The fifth and sixth growth factor-like domains of thrombomodulin bind to the anion-binding exosite of thrombin and alter its specificity
40. Microthrombomodulin. Residues 310-486 from the epidermal growth factor precursor homology domain of thrombomodulin will accelerate protein C activation
41. Structural basis for the anticoagulant activity of the thrombin-thrombomodulin complex